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Professor Michael Oelgemöller, 
recipient of an AITHM 2013 
Development Grant
Associate Professor 
Michael Oelgemöller is 
a leading expert in green 
(solar) photochemistry, 
????????? ???????????????
and photocatalysis. He 
received his Diploma 
from the University of 
Münster in 1995 and his 
PhD from the University of Cologne in 1999. 
He was a researcher at the ERATO-JST 
Photochirogenesis project in Osaka (1999-
2001) and at Bayer CropScience Japan in 
Yuki (2001-2004). From 2004-2008 he held a 
position as a lecturer in Organic and Medicinal 
Chemistry at Dublin City University, Ireland. In 
February 2009 he joined James Cook University 
in Australia as an Associate Professor in 
Organic Chemistry. He received the Kurt-Alder 
award of the University of Cologne in 2000 and 
the Bayer Employee award of the Research 




Tell us about your area of research?
My research is dedicated to applied and green 
photochemistry, so almost everything that 
?????????????????????????????????????????????????
natural light. Our projects span across the entire 
spectrum of pharmaceutical and chemical 
research, ranging from the development of 
????????????? ?????? ????? ?????????? ?????? ???
the production of chemicals, photostability 
testing and photolytic degradation. All of these 
processes match seamlessly with JCU’s motto 
‘crescente luce – light ever increasing’.
What interests you about working in this area?
I ‘saw the light’ when I did a research project 
as an undergraduate student at the University 
of Münster, Germany. I have since been 
fascinated by the possibilities that light 
energy offers in terms of chemical synthesis, 
waste treatment or disease prevention. Many 
of these applications are not possible with 
conventional ‘dark’ methods. When I worked 
for Bayer CropScience, photochemistry was 
often blamed when a pesticide candidate 
??????? ??? ???? ?????? ????????? ?????? ???? ???????
provided. Instead, light can be very creative 
and it allows generating complex molecules 
????? ?? ?????? ??? ?? ????????? ??????????????? ??????
can degrade chemical or microbial pollutants, 
which offers important medical, environmental 
or aquacultural applications. I personally enjoy 
our work on solar photochemistry and North 
Queensland’s 300 days of sunshine were 
one of the main reasons for me to come to 
Townsville from much less sun-blessed Dublin.
How do you see your research developing in 
the future?
We are well-known for our solar work and 
????? ????????????? ????????? ?????? ??????????
scale productions of fragrances and platform 
chemicals. More recently, we went the 
opposite direction and have started work on 
??????????????????????????????????????????????
‘lab & light on a chip’. I would like to combine 




fragrances such as rose oxide or antimalarials 
such as artemisinin. This simple technology 
would enable local producers to add value 
to their products and commodities. We also 
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became interested in the solarthermal synthesis 
of insect repellents from local essential oils. We 
have done some laboratory experiments already 
and the results are remarkable. I hope we will 
be able to generate some proof-of-concept 
funding for this new project in the future. After 
all, prevention is always better than curing.
How has the AITHM funding helped your research 
develop?
The AITHM funding allowed me to match some 
seed funding from the Clinton Health Access 
Initiative. It was really rewarding when this 
????????????????????????????????????????????
ago regarding a potential collaboration on 
artemisinin. The idea behind this project is to 
???????????????????????????????????????????? ????????
in a small production plant. Instead of a traditional 
??????????????????????????? ????????????? ???????
could produce on-site and on-demand where 
needed. This makes it especially attractive for 
?????????????????????????????????????????????????
PNG. If successful, the project could also open 
substantial follow-up funding from the Clinton 
Health Access Initiative. The project also nicely 
complements the existing activities of the AITHM 
on malaria.
What has been the highlight of your science 
career so far?
Thus far I have enjoyed a successful research 
career and have worked in a number of very 
different countries, spending time in the U.S.A, 
South Korea, Japan, Ireland and now Australia. 
None of that was ever in my mind when I started 
my degree in 1989. It is very rewarding when a 
breakthrough is achieved in a project or when 
results come together as a whole. I also enjoy 
working with the diversity of students in my 
group, which consists mainly of visiting students 
from all over the world. This international team 
has created a lively and creative environment. 
It would be great to be able to keep some of the 
students though.
What would you like to do in the future?
I am very open for collaborations and do not mind 
low- or even no-budget projects. Something I 
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Figure 2: Solar reactors: (A) CPC-reactor at JCU; and (B) PROPHIS-loop at the DLR in Germany.
would really like to pursue in the future is getting into health care. Some of our projects on small-
??????????????????????????????????????????????????????????????????????????????????? ??????????????
and remote communities in the tropics. So my guiding principle is once again ‘crescente luce – light 
ever increasing’!
???????? ??? ?????? ???????? ?????????? ???
an AITHM 2013 Development Grant
Dr Paula Clancy leads 




and Tissue) research 
group at James Cook 




and their patients within one research group to 
tackle the issues of diabetes and its associated 
complications.
Email: paula.clancy@jcu.edu.au
Tell us about your area of research?
So far my post-doctoral research has involved 
investigating protein signalling pathways in 
atherosclerosis. Using cultured human carotid 
atheroma explant culture I have investigated 
the impact of various commonly used drugs, 
such as angiotensin receptor blockers (ARBs), 
???????????? ??????????? ??????? ???????????
(ACEis) and statins on the chronic up-regulation 
????????????????????????????????????????????
Following on from my previous studies I have 
now set up a new research group called HART-
BEAT (Health practitioners And Researchers 
Together-Blood, Endothelium And Tissue) which 
aims to investigate secondary complications in 
diabetes, in particular cardiovascular disease; 
mental health issues, including depression and 
anxiety; impaired wound healing; and increased 
??????????? ??????????? ???????????? ???????????
such as cytokines, proteases, growth factors and 
